TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean Change From Baseline in Binocular Distance Corrected Near Visual Acuity (DCNVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in inspiratory muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strengths and Difficulties Questionnaire - Parent version (SDQ-P)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Turgay DSM-IV Disruptive Behavior Disorders Rating Scale (T-DSM-IV-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Presence of Block Quality Components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: University of Miami Parkinson's Disease Hallucinations Questionnaire (UM-PDHQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 7-item Auditory Hallucinations Rating Scale (AHRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of air trapping and consolidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete and correct foot roll-off
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changed walking speed/greater number of steps per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of women with perineal pain score < 3 NRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perineal pain intensity according to NRS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration (Cmax) of SHR0302
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve (AUC) of SHR0302
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative bioavailability of SHR0302 tablets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contraceptive effectiveness after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in clinical efficacy of hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective muscle strength measured by a handheld dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant self-reported outcome for pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in atrial Fibrillation events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall performance
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion who have had a sexual health discussion with medical professional
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion who know their HPV vaccination status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion who have been vaccinated for HPV
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in Treatment Areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doubling of serum creatinine from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change from baseline in total corneal fluorescein staining (CFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain self-efficacy (PSEQ-4)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EuroQol-5 Dimension-5 Levels (EQ5D5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in EuroQol five dimensions questionnaire (EQ-5D-Y) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in the Child Health Utility 9D (CHU9D) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Biopsy outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with improved estimation of Trials to Criterion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased adherence to prescribed dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of clinics and providers that actively use Acuity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: time to hemodynamic stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance fatigability
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Retinal neurovascular coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rosenberg Self-Esteem Scale (RSES)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mammogram Completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to Lung Cancer
Endpoint domain: Mortality/survival
Primary endpoint: Performance of fiberoptic bronchoscopy (FOB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pregnancy rate during three months
Endpoint domain: Mortality/survival
Primary endpoint: Pregnancy rate during six months
Endpoint domain: Mortality/survival
Primary endpoint: Termination rate during three months
Endpoint domain: Mortality/survival
Primary endpoint: Contractile properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge scores of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Skill levels of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Heart Rate Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Pressure Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in size of lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking relapse rate
Endpoint domain: Adverse events/effects
Primary endpoint: Physical condition (Maximal oxygen consumption)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back pain (Nordic Questionnaire)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Satisfaction with life (Life Satisfaction Scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Numbers of Lesions With no Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Numbers of Lesions With Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Numbers of Lesions With Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hip-Knee-Ankle Joint Position Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tidal esophageal pressure swing (∆Pes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dental Subscale of Children's Fear Survey Schedule parental version (CFSS-DS pv)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Venham Picture Test (VPT)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Facial Image Scale (FIS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bracket bonding survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Rate of rhythmic recurrence of ventricular rhythm disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUCinf of everolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Everolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmin,ss,pred of Everolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in hair tensile strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of epistaxis duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Frequency of Cannabis Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cannabis Withdrawal Scale (CWS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Kessler Psychological Distress Scale (K10) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Usability of the application
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with the application-driven follow-up
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Long-term adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Oxford Agoraphobic Avoidance Scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Systems Usability Scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Gluteus maximus strength with a dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change in blood advanced glycation end products level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in blood leptin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in blood adiponectin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concurrent validity (sensitivity and specificity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of collected patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants with Adverse Events (AEs), AE of Special Interest (AESIs), and Serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of MACCE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of symptoms showing favorable change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Depression Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Self efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot and Ankle Mobility Measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain levels based on the Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain levels based on Patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin fold thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Estimation of total body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in controlled attenuation parameter (CAP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in fasting serum triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in the Average Minutes of Moderate and Vigorous Physical Activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean HP 13C-pyruvate to lactate metabolic rate of conversion (kPL) over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean HP 13C-pyruvate to glutamate metabolic rate of conversion (kPG) over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean kPL at time of biochemical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Fear of Falling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Amygdala activation during stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Insula activation during social exclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Score Changes on the FACT/GOG-Ntx questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dual-energy X-ray absorptiometry (DXA) scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross motor function measurement scale (GMFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Questionnaire for Children (CP QOL-Child)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Homa-IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adequacy of antibiotic prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Symptoms of long-COVID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in neurological deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: status of stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Stride length mean distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stride time mean time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed mean distance/time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cadence mean number of steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of MFS in detecting Fibrotic NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: percentage of patients with nasal mucosa granuloma and lymphocytic infiltrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Comparison Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frailty assessment completion time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frailty assessment completion rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: occurrence rates of acute respiratory distress syndrome (ARDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sutural Displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wave I-VII amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Wave I-VII latencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Wave I-VII interpeak intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinically acceptable image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pain and irritability score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Infract Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motivation to Quit
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: % change in 24-hour urinary oxalate excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Information dissemination and retention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of intervention sessions completed by participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recording the number of drop out rates from participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximum tolerated concentration of SN514 gel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to first neurologic assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subject Retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of eligible patients choosing to participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ED/EA incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of use of GDMT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 24 month progression free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Bacterial and fungal species bound to the dressing
Endpoint domain: Adverse events/effects
Primary endpoint: Successful peripheral venous vein placement on first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in T2 Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Willingness to receive HPV vaccines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in NRS scores for average itching severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of RNA-LP vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Determination of Maximum Tolerated Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective response based on RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Self-efficacy Pretest Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions Pretest Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge Posttest Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Varicose vein diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: intention to infection control behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: knowledge of infection control
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of somatic mutations in leukemic cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Initiation timing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Turning velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increasing comfort level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in skin spot level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in hyperpigmentation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Adverse effect after using the topical cream
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants that complete the 56-day treatment period
Endpoint domain: Adverse events/effects
Primary endpoint: Differential changes in gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrollment Number
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of Exit-site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Infectious peritonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Hospital's diagnostic and treatment standards for invasive fungal infections
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Awareness of invasive fungal infection among intensive care physicians
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Minimum effective dose of ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24h systolic BP drop value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Wilms' tumour recurrence and progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cranial nerves abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time 0 Extrapolated to Infinity (AUCinf) of Sotorasib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration (AUC0-tlast) of Sotorasib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain after Endometrial Biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Adverse Events (AEs), Serious Adverse Events (SAEs), and Adverse Events leading to discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Schirmer's Tear Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intention to use immersive virtual reality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status